Wuxi Biologics (Cayman) Inc. has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the issuance of a total of 3,653,100 new shares. These shares were issued as part of the exercise of share options under the company's Pre-IPO Share Option Scheme. The shares were issued at prices of HKD 1.98 and HKD 1.29.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.